Safety and efficacy of fimasartan in Mexican patients with grade 1–2 essential hypertension-Reference-Cited by-同舟云学术

Safety and efficacy of fimasartan in Mexican patients with grade 1–2 essential hypertension

Published:2017-10 Issue:4 Volume:87 Page:316-325
ISSN:1405-9940
Container-title:Archivos de Cardiología de México
language:en
Short-container-title:Archivos de Cardiología de México

Author:

Cardona-Muñoz Ernesto G.,López-Alvarado Agustín,Conde-Carmona Ignacio,Sánchez-Mejorada Gerardo,Pascoe-González Sara,Banda-Elizondo Ramiro G.,García-Castillo Armando,González-Gálvez Guillermo,Velasco-Sánchez Raúl G.,Vidrio-Velázquez Maricela,Leiva-Pons José L.,Villeda-Espinosa Efraín,Guerra-López Arturo,Esturau-Santalo Ramón M.

Publisher

Publicidad Permanyer, SLU

Subject

Cardiology and Cardiovascular Medicine

Link

http://www.archivoscardiologia.com/previos/(2017)%20ACM%20Vol%2087.%204%20OCTUBRE-DICIEMBRE/ACMX_2017_87_4_316-325.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Pressure–lowering Effect of Fimasartan Versus Comparators: A Cross-inference With a Systematic Review and Meta-analysis Through a Quality-management System;Clinical Therapeutics;2023-05

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)

;Drug Design, Development and Therapy;2020-01

3. Fimasartan: A new armament to fight hypertension;Journal of Family Medicine and Primary Care;2019

4. PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2018-05-04

5. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians;Drug Design, Development and Therapy;2018-04